Astellas Pharma, Inc. (ALPMY)
14.67
+0.22
(+1.52%)
USD |
OTCM |
May 08, 16:00
Astellas Pharma Shareholders Equity (Quarterly) : 11.51B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 90.10B |
| Takeda Pharmaceutical Co., Ltd. | 48.76B |
| Daiichi Sankyo Co., Ltd. | 10.91B |
| Eisai Co., Ltd. | 5.676B |
| Chugai Pharmaceutical Co., Ltd. | 11.99B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.42B |
| Total Liabilities (Quarterly) | 10.91B |
| Debt to Equity Ratio | 0.3091 |
| Current Ratio | 1.167 |
| Net Debt Paydown Yield | 2.07% |